Nancy J Hutson Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nancy J Hutson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nancy J Hutson. Nancy J Hutson is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INSPIRE PHARMACEUTICALS INC ($ISPH) and Director in PhaseBio Pharmaceuticals Inc ($PHAS) and Director in Clearside Biomedical, Inc. ($CLSD) and Director in Endo International plc ($ENDP).
Nancy J Hutson in BIOCRYST PHARMACEUTICALS INC
Trading Symbol: BCRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Nancy J Hutson: Director
Holdings: 64,756 shares
Current Value: $367,167
Latest Transaction: Mar 02 2021
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Nancy J Hutson in BIOCRYST PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCRX, CLSD, ENDP, ISPH, PHAS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2021 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 10.78 | 463 | 4,991 | 64,756 | 64.3 K to 64.8 K (+0.72 %) |
Mar 02 2021 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 10.78 | 463 | 4,991 | 64,756 | 64.3 K to 64.8 K (+0.72 %) |
Dec 02 2020 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 5.11 | 978 | 4,998 | 64,293 | 63.3 K to 64.3 K (+1.54 %) |
Sep 02 2020 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 4.15 | 1,204 | 4,997 | 63,315 | 62.1 K to 63.3 K (+1.94 %) |
Sep 02 2020 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 4.15 | 1,204 | 4,997 | 63,315 | 62.1 K to 63.3 K (+1.94 %) |
May 14 2020 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 5.41 | 40,000 | 216,400 | 40,000 | |
Dec 03 2019 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 2.85 | 3,508 | 9,998 | 56,554 | 53 K to 56.6 K (+6.61 %) |
Nov 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Buy | P | 1.45 | 10,000 | 14,500 | 53,046 | 43 K to 53 K (+23.23 %) |
Sep 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 2.99 | 3,344 | 9,999 | 43,046 | 39.7 K to 43 K (+8.42 %) |
May 31 2019 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 2.91 | 30,000 | 87,300 | 30,000 | |
Jun 22 2018 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 6.09 | 30,000 | 182,700 | 30,000 | |
Jun 04 2018 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 6.43 | 1,555 | 9,999 | 39,702 | 38.1 K to 39.7 K (+4.08 %) |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 4.97 | 2,012 | 10,000 | 38,147 | 36.1 K to 38.1 K (+5.57 %) |
Dec 04 2017 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 5.08 | 1,968 | 9,997 | 36,135 | 34.2 K to 36.1 K (+5.76 %) |
Sep 05 2017 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 5.10 | 1,960 | 9,996 | 34,167 | 32.2 K to 34.2 K (+6.09 %) |
Jun 02 2017 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 5.15 | 1,941 | 9,996 | 32,207 | 30.3 K to 32.2 K (+6.41 %) |
May 25 2017 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 30,000 | |
Mar 02 2017 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 6.24 | 1,602 | 9,996 | 30,266 | 28.7 K to 30.3 K (+5.59 %) |
Dec 02 2016 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 5.59 | 1,788 | 9,995 | 28,664 | 26.9 K to 28.7 K (+6.65 %) |
Sep 06 2016 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 4.11 | 2,433 | 10,000 | 26,876 | 24.4 K to 26.9 K (+9.95 %) |
Jun 02 2016 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 3.39 | 2,581 | 8,750 | 24,443 | 21.9 K to 24.4 K (+11.81 %) |
May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 3.22 | 30,000 | 96,600 | 30,000 | |
Mar 01 2016 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 1.99 | 4,396 | 8,748 | 21,862 | 17.5 K to 21.9 K (+25.17 %) |
Dec 03 2015 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 10.61 | 824 | 8,743 | 17,466 | 16.6 K to 17.5 K (+4.95 %) |
Sep 02 2015 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 11.64 | 751 | 8,742 | 16,642 | 15.9 K to 16.6 K (+4.73 %) |
May 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 11.39 | 15,000 | 170,850 | 15,000 | |
Feb 23 2015 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Buy | P | 10.27 | 10,000 | 102,700 | 15,891 | 5.9 K to 15.9 K (+169.75 %) |
Page: 1